Sawhney Roger bought ABUS

September 18, 2026 · Form 4 insider transaction

Sawhney Roger bought 52,533 shares of Arbutus Biopharma Corporation at $3.34 per share, a transaction worth $175.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
52,533
Price
$3.34
Total value
$175.5K
Role—
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateSeptember 18, 2026
Filing dateSeptember 23, 2026
Shares owned after52,533
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR